Primitive Neuroectodermal Tumor: Clinical Trials

7 trials for Primitive Neuroectodermal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 2, Recruiting 2, Active not recruiting 1, Unknown 1, Withdrawn 1
Phase 21Unknown 1

Follow Primitive Neuroectodermal Tumor: new trials by email Literature Review of Primitive Neuroectodermal Tumor trials Research Report on Primitive Neuroectodermal Tumor

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
Etoposide, Fludarabine Phosphate, Hematopoietic Cell Transplantation - Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor
Phase 1WithdrawnM.D. Anderson Cancer Center2021-01-142024-10-26
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel - Central Nervous System Tumor, Diffuse Intrinsic Pontine Glioma
Phase 1RecruitingSeattle Children's Hospital902019-12-112026-04-13
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
EGFR806-specific chimeric antigen receptor (CAR) T cell - Central Nervous System Tumor, Pediatric, Glioma
Phase 1CompletedSeattle Children's Hospital112019-03-192025-12-17
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
HER2-specific chimeric antigen receptor (CAR) T cell - Central Nervous System Tumor, Pediatric, Glioma
Phase 1Active not recruitingSeattle Children's Hospital102018-07-262025-12-17
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Gemcitabine, ribociclib, sonidegib - Anaplastic Astrocytoma, Anaplastic Ependymoma
Phase 1CompletedSt. Jude Children's Research Hospital682018-03-052024-05-31
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
TCRαβ+/CD19+ depleted Haploidentical HSCT, Zoledronate - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 1RecruitingUniversity of Wisconsin, Madison222016-02-122026-10-27
Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Carboplatin, Mannitol, Melphalan - Central Nervous System Embryonal Neoplasm, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered
Phase 1 / Phase 2UnknownOHSU Knight Cancer Institute172009-07-092021-10-26

Narrower conditions

Neuroectodermal Tumors, Primitive (7)  ·  Medulloblastoma (6)  ·  Brain Neoplasms (5)  ·  Choroid Plexus Carcinoma (5)  ·  Ependymoma (5)  ·  Glioma (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Rhabdoid Tumor (5)  ·  Central Nervous System Neoplasms (4)  ·  Pinealoma (4)  ·  Astrocytoma (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Glioblastoma (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Myeloid, Acute (1)

Broader conditions

Neoplasms by Histologic Type (7)  ·  Neoplasms, Glandular and Epithelial (7)  ·  Neoplasms, Nerve Tissue (7)  ·  Neuroectodermal Tumors (7)  ·  Neoplasms (6)  ·  Neoplasms, Neuroepithelial (6)  ·  Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Neoplasms by Site (5)  ·  Neoplasms, Complex and Mixed (5)  ·  Nervous System Diseases (5)  ·  Nervous System Neoplasms (5)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)

Interventions

Automobiles (3)  ·  Melphalan (2)  ·  Antilymphocyte Serum (1)  ·  Carboplatin (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Gemcitabine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Mannitol (1)  ·  Mycophenolic Acid (1)  ·  Stem Cell Transplantation (1)  ·  Tacrolimus (1)  ·  Thiotepa (1)  ·  Zoledronic Acid (1)

Sponsors

Seattle Children's Hospital (3)  ·  M.D. Anderson Cancer Center (1)  ·  OHSU Knight Cancer Institute (1)  ·  St. Jude Children's Research Hospital (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (6)

Top investigators

Rebecca Ronsley, MD (2)  ·  Christian Capitini, MD (1)  ·  Edward A Neuwelt (1)  ·  Giles W. Robinson, MD (1)  ·  Juliane Gust, MD, PhD (1)  ·  Kris M Mahadeo, MD (1)

Results publications

PMID 31401903, PMID 34253928, PMID 35468680, PMID 37640679, PMID 39775044, PMID 41798119

NIH funding

R01NS044687 (1)